Clinical trial
Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV…
NCT00093522 · St. Luke's Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00093522 |
|---|---|
| Title | Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer |
| Official title | A Phase II Pilot Study of Tumor-Loaded Dendritic Cells Alone or Following a Non-Myeloablative Conditioning Regimen in Patients With Metastatic Renal Cell Carcinoma |
| Lead sponsor | St. Luke's Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | autologous tumor cell vaccine, keyhole limpet hemocyanin, therapeutic autologous dendritic cells, fludarabine phosphate, conventional surgery |
| Enrollment | 28 |
| Start date | Aug 1, 2004 |
| First posted | Oct 8, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: